Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37024465)

  • 1. CMTR1 promotes colorectal cancer cell growth and immune evasion by transcriptionally regulating STAT3.
    You AB; Yang H; Lai CP; Lei W; Yang L; Lin JL; Liu SC; Ding N; Ye F
    Cell Death Dis; 2023 Apr; 14(4):245. PubMed ID: 37024465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The autophagy-independent role of BECN1 in colorectal cancer metastasis through regulating STAT3 signaling pathway activation.
    Hu F; Li G; Huang C; Hou Z; Yang X; Luo X; Feng Y; Wang G; Hu J; Cao Z
    Cell Death Dis; 2020 May; 11(5):304. PubMed ID: 32358527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
    Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
    Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL-6-STAT3 pathway.
    Wang J; Zhou J; Jiang C; Zheng J; Namba H; Chi P; Asakawa T
    Mol Oncol; 2019 Nov; 13(11):2344-2360. PubMed ID: 31246342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E; Rasmi Y; Baradaran B
    J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Lu J; Zhang L; Zhou H; Du Z; Zhang G
    Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhi L; Zhao L; Zhang X; Liu W; Gao B; Wang F; Wang X; Wang G
    Aging (Albany NY); 2021 Sep; 13(18):22164-22175. PubMed ID: 34526411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer.
    Pan H; Pan J; Ji L; Song S; Lv H; Yang Z; Guo Y
    Int J Biol Macromol; 2019 Oct; 138():125-134. PubMed ID: 31279884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation.
    Jia L; Wang Y; Wang CY
    Adv Sci (Weinh); 2021 Jul; 8(13):2003376. PubMed ID: 34258151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZNF32 promotes the self-renewal of colorectal cancer cells by regulating the LEPR-STAT3 signaling pathway.
    Li J; Li X; Lan L; Sun L; Li X; Li Y; Tian Y; Zhang T; Zhou Y; Mo C; Fu X
    Cell Death Dis; 2022 Feb; 13(2):108. PubMed ID: 35115495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
    He T; Cui J; Wu Y; Sun X; Chen N
    Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RING-Finger Protein 6 Amplification Activates JAK/STAT3 Pathway by Modifying SHP-1 Ubiquitylation and Associates with Poor Outcome in Colorectal Cancer.
    Liang Q; Ma D; Zhu X; Wang Z; Sun TT; Shen C; Yan T; Tian X; Yu T; Guo F; Tang J; Lin Y; Chen H; Zhou C; Ge Z; Zhong M; Chen J; Liu Q; Wang Z; Fang JY; Chen H; Hong J
    Clin Cancer Res; 2018 Mar; 24(6):1473-1485. PubMed ID: 29288235
    [No Abstract]   [Full Text] [Related]  

  • 16. The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.
    Nivarthi H; Gordziel C; Themanns M; Kramer N; Eberl M; Rabe B; Schlederer M; Rose-John S; Knösel T; Kenner L; Freund P; Aberger F; Han X; Kralovics R; Dolznig H; Jennek S; Friedrich K; Moriggl R
    Oncotarget; 2016 Aug; 7(32):51096-51106. PubMed ID: 27191495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway.
    Xue J; Liao L; Yin F; Kuang H; Zhou X; Wang Y
    Cancer Biomark; 2018; 21(4):849-858. PubMed ID: 29439310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circular RNA circSPARC enhances the migration and proliferation of colorectal cancer by regulating the JAK/STAT pathway.
    Wang J; Zhang Y; Song H; Yin H; Jiang T; Xu Y; Liu L; Wang H; Gao H; Wang R; Song J
    Mol Cancer; 2021 Jun; 20(1):81. PubMed ID: 34074294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 20. FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway.
    Li P; Huang T; Zou Q; Liu D; Wang Y; Tan X; Wei Y; Qiu H
    J Immunol; 2019 May; 202(10):3065-3075. PubMed ID: 30979816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.